ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

November 22, 2006

New NCI Journal Patterned On “Science”

March 20, 1987

In Brief: Dmitrovsky Named Provost at MD Anderson; Paulsen Leaves To Chair Duke Radiology

April 12, 2013

ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials

December 31, 2010

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989

Postoperative Chemo Doesn’t Improve Survival, Study Finds

March 28, 2008